Table 6.
Actual long-term survivors: Following surgery for HCC with PVTT
TP | Age/sex | Vp | Surgical resection | Adjuvant therapy | Survival/status |
---|---|---|---|---|---|
TP1 | 48 years/M | Vp1 | Yes | Pre- and postoperative TACE | 4 years 10 months DOD |
TP1 | 56 years/M | Vp2 | Yes | Preoperative TACE | 5 years 9 months DOD |
TP1 | 59 years/M | Vp3 | Yes | Pre- and postoperative TACE | 4 years 2 months DOD |
TP2 | 42 years/M | Vp3 | Yes | Preoperative TACE | 3 years 6 months NED |
TP2 | 64 years/F | Vp3 | Yes | Postoperative TACE | 4 years 1 months DOD |
TP2 | 43 years/M | Vp2 | Yes | Preoperative TACE | 4 years 9 months DOD |
TP2 | 57 years/M | Vp3 | Yes | Preoperative TACE | 8 years 5 months NED |
TP2 | 65 years/M | Vp1 | Yes | Preoperative TACE | 5 years 9 months NED |
TP2 | 57 years/M | Vp3 | Yes | Pre- and postoperative TACE | 3 years 7 months DOD |
TP2 | 33 years/M | Vp1 | Yes | Postoperative TACE | 4 years 1 months DOD |
TP2 | 45 years/M | Vp2 | Yes | Preoperative TACE | 7 years 3 months NED |
TACE transcatheter hepatic arterial chemoembolization, DOD dead of disease, NED no evidence of disease